Breast Cancer
Latest News
Advertisement
Latest Videos
CME Content
Advertisement
More News
In postmenopausal diabetic women, metformin use was associated with lower ER and PR breast cancer incidence.
Dr. Debu Tripathy from UC Norris Cancer Center Discusses HER2 Targeted Therapies
Patients with breast cancer who undertook yoga following radiotherapy derived physical and emotional benefi ts from the ancient Indian practice, according to research presented at ASCO.
Dr. Mary J. C. Hendrix from Northwestern University's Feinberg School of Medicine on Metastatic Tumor Cells in Microenvironments
Dr. Debu Tripathy from USC Norris Cancer Center on Completing New Assays After Recurrence
Breast cancer survivors who stop working during chemotherapy may face the loss of long-term employment for several years after their diagnosis.
Dr. Joyce A. O'Shaughnessy from Baylor Sammons Cancer Center on Avastin as Her Standard of Care
A randomized trial comparing survivorship care plans with standard oncologist discharge visits in patients with breast cancer found no differences in outcomes among the groups.
Dr. Debu Tripathy from USC Norris Cancer Center Describes the Benefits of the PER Conferences
Dr. Antonio C. Wolff from Sidney Kimmel Comprehensive Cancer Center Discusses the Importance of HER2 Testing
Dr. Debu Tripathy from USC Norris Cancer Center on the Oncotype DX Assay Recurrence Score
Dr. Joyce A. O'Shaughnessy from Baylor Sammons Cancer Center on Continued Access to Avastin
Dr. Debu Tripathy from USC Norris Cancer Center Discusses Breast Cancer Gene Profiling
Dr. Debu Tripathy from the USC Norris Comphrensive Cancer Center Discusses Breast Cancer Biomarkers
Recent study findings raise questions about how well computers interpret mammograms.
An exploratory analysis of the phase III EMBRACE trial of eribulin mesylate in metastatic breast cancer found the survival benefit and toxicity profile to be independent of age.
Dr. Mark G. Kris from Memorial Sloan-Kettering Cancer Center Discusses Patient Acceptance of Mutation Testing
On July, 29, 2011, a US appeals court sided with Myriad Genetics, Inc's patents on the BRCA1 and BRCA2 genes.
Postmenopausal women at risk of breast cancer got good news from the MAP.3 trial results: Exemestane reduced their risk of invasive breast cancer by 65% compared with placebo.
Dr. Sandhya Pruthi from the Mayo Clinic in Minnesota on What She Learned From the Flaxseed Trial
It had been thought that removing the sentinel node and the surrounding lymph nodes would improve survival rates.
Dr. Sandya Pruthi from the Mayo Clinic in Minnesota Examines the Options Available for Hot Flashes after the failure of flaxseed
Dr. Mark G. Kris from Memorial Sloan-Kettering cancer center Explains How Gene Signatures are Used
The American College of Obstetricians and Gynecologists this week recommended annual mammography screenings for women starting at age 40.
The NCCN voted to maintain the current recommendation and position on Avastin (bevacizumab) in its treatment of metastatic breast cancer.
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
3
Novel Targeted Agents Are Poised to Influence the MPN Treatment Paradigm: With John O. Mascarenhas, MD
4
Aligning Patient Goals and Toxicity Burden Are Key in First-Line Chemo Selection in Pancreatic Cancer
5